ANXA11 and cancer: Since ANXA11 plays a role in apoptosis modulation, it could represent an important player in cancer therapies based on targeting apoptotic pathways and/or the development of resistance mechanisms, and hence emerge as a valuable biomarker to predict treatment response or to identify/stratify the subset of patients who are likely to respond (Song et al., 2022).